Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histiocytosis, Langerhans-Cell | 3 | 2015 | 240 | 0.480 |
Why?
|
| Colitis | 2 | 2024 | 164 | 0.350 |
Why?
|
| Neoplasms, Second Primary | 2 | 2014 | 150 | 0.340 |
Why?
|
| Langerhans Cells | 2 | 2015 | 21 | 0.340 |
Why?
|
| Eosinophilic Esophagitis | 3 | 2016 | 56 | 0.320 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2014 | 541 | 0.280 |
Why?
|
| Cephalexin | 1 | 2006 | 7 | 0.260 |
Why?
|
| Loss of Heterozygosity | 1 | 2007 | 131 | 0.260 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2007 | 216 | 0.240 |
Why?
|
| Drug Hypersensitivity | 1 | 2006 | 100 | 0.240 |
Why?
|
| Myocarditis | 1 | 2006 | 132 | 0.240 |
Why?
|
| Myofibromatosis | 1 | 2025 | 10 | 0.230 |
Why?
|
| Genetic Markers | 1 | 2007 | 623 | 0.230 |
Why?
|
| Mannose-Binding Lectins | 1 | 2004 | 26 | 0.230 |
Why?
|
| Lectins, C-Type | 1 | 2004 | 74 | 0.220 |
Why?
|
| Alcoholic Beverages | 1 | 2004 | 18 | 0.220 |
Why?
|
| Antigens, Surface | 1 | 2004 | 117 | 0.220 |
Why?
|
| Alcoholic Intoxication | 1 | 2004 | 11 | 0.220 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2008 | 782 | 0.190 |
Why?
|
| Testicular Neoplasms | 2 | 2017 | 131 | 0.190 |
Why?
|
| Oncostatin M Receptor beta Subunit | 1 | 2021 | 1 | 0.180 |
Why?
|
| Oncostatin M | 1 | 2021 | 5 | 0.180 |
Why?
|
| Yttrium Radioisotopes | 1 | 2020 | 19 | 0.170 |
Why?
|
| Embolization, Therapeutic | 2 | 2020 | 224 | 0.160 |
Why?
|
| Hepatoblastoma | 1 | 2020 | 183 | 0.140 |
Why?
|
| Testicular Diseases | 1 | 2017 | 12 | 0.140 |
Why?
|
| Calculi | 1 | 2017 | 15 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 311 | 0.140 |
Why?
|
| Behcet Syndrome | 1 | 2017 | 17 | 0.130 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2016 | 24 | 0.130 |
Why?
|
| Immunoglobulin E | 2 | 2014 | 171 | 0.130 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2016 | 18 | 0.120 |
Why?
|
| Child | 15 | 2021 | 25847 | 0.120 |
Why?
|
| Child, Preschool | 9 | 2020 | 14865 | 0.120 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 173 | 0.120 |
Why?
|
| Urinary Bladder | 2 | 2014 | 252 | 0.120 |
Why?
|
| Thymus Hyperplasia | 1 | 2015 | 1 | 0.120 |
Why?
|
| Thymus Gland | 1 | 2015 | 106 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 2575 | 0.110 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 146 | 0.110 |
Why?
|
| Humans | 29 | 2025 | 133181 | 0.110 |
Why?
|
| Ganglioglioma | 1 | 2014 | 22 | 0.110 |
Why?
|
| Lipoma | 1 | 2014 | 26 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2014 | 103 | 0.110 |
Why?
|
| Fasciitis | 1 | 2014 | 20 | 0.110 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2014 | 33 | 0.110 |
Why?
|
| Fibroma | 1 | 2014 | 31 | 0.110 |
Why?
|
| Rhabdoid Tumor | 1 | 2014 | 56 | 0.110 |
Why?
|
| Joint Diseases | 1 | 2014 | 34 | 0.110 |
Why?
|
| Arthroscopy | 1 | 2014 | 45 | 0.110 |
Why?
|
| Mydriasis | 1 | 2013 | 8 | 0.100 |
Why?
|
| Basophils | 1 | 2013 | 11 | 0.100 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2013 | 31 | 0.100 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2013 | 32 | 0.100 |
Why?
|
| Ribonuclease III | 1 | 2014 | 103 | 0.100 |
Why?
|
| Muscle, Smooth | 1 | 2013 | 135 | 0.100 |
Why?
|
| Cytokines | 3 | 2016 | 1377 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 592 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 150 | 0.100 |
Why?
|
| Knee Joint | 1 | 2014 | 171 | 0.100 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2014 | 205 | 0.100 |
Why?
|
| Wilms Tumor | 1 | 2014 | 119 | 0.100 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2014 | 128 | 0.100 |
Why?
|
| Polyradiculopathy | 1 | 2012 | 2 | 0.100 |
Why?
|
| Autophagy | 1 | 2016 | 431 | 0.100 |
Why?
|
| Low Back Pain | 1 | 2012 | 40 | 0.090 |
Why?
|
| Male | 17 | 2025 | 65478 | 0.090 |
Why?
|
| Spinal Neoplasms | 1 | 2012 | 76 | 0.090 |
Why?
|
| Sarcoma | 1 | 2014 | 209 | 0.090 |
Why?
|
| Antitubercular Agents | 1 | 2013 | 265 | 0.090 |
Why?
|
| Orbital Pseudotumor | 1 | 2011 | 10 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2014 | 664 | 0.090 |
Why?
|
| Hemangioma | 1 | 2012 | 96 | 0.090 |
Why?
|
| Cellulitis | 1 | 2011 | 63 | 0.090 |
Why?
|
| Colon | 1 | 2013 | 373 | 0.090 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2011 | 59 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2016 | 4915 | 0.080 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 167 | 0.080 |
Why?
|
| Blindness | 1 | 2011 | 76 | 0.080 |
Why?
|
| Proteins | 1 | 2016 | 1090 | 0.080 |
Why?
|
| Phosphotransferases | 1 | 2010 | 41 | 0.080 |
Why?
|
| Anti-HIV Agents | 1 | 2013 | 350 | 0.080 |
Why?
|
| Teratoma | 1 | 2011 | 130 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1404 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2025 | 8627 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 460 | 0.080 |
Why?
|
| Adolescent | 9 | 2017 | 20549 | 0.080 |
Why?
|
| Mesentery | 1 | 2009 | 27 | 0.080 |
Why?
|
| Mutation, Missense | 1 | 2014 | 940 | 0.080 |
Why?
|
| Infant | 6 | 2015 | 13235 | 0.080 |
Why?
|
| Janus Kinase 2 | 1 | 2010 | 134 | 0.080 |
Why?
|
| Frameshift Mutation | 1 | 2010 | 201 | 0.080 |
Why?
|
| Myeloproliferative Disorders | 1 | 2010 | 91 | 0.080 |
Why?
|
| Intestinal Volvulus | 1 | 2009 | 40 | 0.070 |
Why?
|
| Female | 14 | 2020 | 71395 | 0.070 |
Why?
|
| Peritoneal Neoplasms | 1 | 2009 | 55 | 0.070 |
Why?
|
| Acute Disease | 2 | 2012 | 1182 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 3863 | 0.070 |
Why?
|
| Intestinal Obstruction | 1 | 2009 | 95 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2010 | 276 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2015 | 2559 | 0.070 |
Why?
|
| Methotrexate | 2 | 2025 | 355 | 0.070 |
Why?
|
| Tuberculosis | 1 | 2013 | 554 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 392 | 0.070 |
Why?
|
| Muscle Cells | 1 | 2006 | 27 | 0.070 |
Why?
|
| Hypothyroidism | 1 | 2008 | 99 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 467 | 0.060 |
Why?
|
| Intestine, Small | 1 | 2009 | 312 | 0.060 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 186 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 1730 | 0.060 |
Why?
|
| Necrosis | 1 | 2006 | 210 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 676 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 558 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 376 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 2144 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 1964 | 0.060 |
Why?
|
| Vinblastine | 1 | 2025 | 58 | 0.060 |
Why?
|
| Antigens, CD1 | 1 | 2004 | 23 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2010 | 871 | 0.060 |
Why?
|
| Hodgkin Disease | 1 | 2007 | 295 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 1405 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2014 | 2718 | 0.050 |
Why?
|
| Eosinophils | 2 | 2016 | 108 | 0.050 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 818 | 0.050 |
Why?
|
| Infant Formula | 1 | 2004 | 100 | 0.050 |
Why?
|
| Esophagus | 2 | 2016 | 218 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 1582 | 0.050 |
Why?
|
| Ethanol | 1 | 2004 | 166 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2004 | 441 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2021 | 17526 | 0.050 |
Why?
|
| Prognosis | 2 | 2015 | 5032 | 0.050 |
Why?
|
| Endoscopy | 1 | 2024 | 280 | 0.050 |
Why?
|
| HIV Infections | 1 | 2013 | 2060 | 0.040 |
Why?
|
| Biopsy | 2 | 2015 | 1201 | 0.040 |
Why?
|
| Disease Progression | 1 | 2007 | 2242 | 0.040 |
Why?
|
| Feces | 1 | 2024 | 783 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2017 | 998 | 0.040 |
Why?
|
| Skin | 2 | 2014 | 542 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 2139 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2025 | 858 | 0.040 |
Why?
|
| Young Adult | 4 | 2015 | 9921 | 0.040 |
Why?
|
| Mice | 4 | 2016 | 18928 | 0.030 |
Why?
|
| Rheumatic Diseases | 1 | 2017 | 73 | 0.030 |
Why?
|
| Janus Kinase 3 | 1 | 2016 | 16 | 0.030 |
Why?
|
| Chloroquine | 1 | 2016 | 32 | 0.030 |
Why?
|
| Philadelphia Chromosome | 1 | 2016 | 43 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2013 | 1049 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2016 | 66 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2016 | 89 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2016 | 3978 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 2751 | 0.030 |
Why?
|
| Epithelium | 1 | 2016 | 354 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2015 | 60 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2016 | 163 | 0.030 |
Why?
|
| Asperger Syndrome | 1 | 2014 | 7 | 0.030 |
Why?
|
| Lipomatosis | 1 | 2014 | 16 | 0.030 |
Why?
|
| SMARCB1 Protein | 1 | 2014 | 48 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 348 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1253 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 482 | 0.030 |
Why?
|
| Hematuria | 1 | 2014 | 55 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 452 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2013 | 125 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 2013 | 82 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 2013 | 237 | 0.020 |
Why?
|
| Animals | 4 | 2016 | 36184 | 0.020 |
Why?
|
| Laminectomy | 1 | 2012 | 24 | 0.020 |
Why?
|
| Biomarkers, Tumor | 2 | 2014 | 1692 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 625 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 368 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 822 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 788 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2012 | 113 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 2012 | 115 | 0.020 |
Why?
|
| Infliximab | 1 | 2011 | 68 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 1083 | 0.020 |
Why?
|
| Eyelid Diseases | 1 | 2011 | 55 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 868 | 0.020 |
Why?
|
| Oculomotor Muscles | 1 | 2011 | 68 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2010 | 34 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 795 | 0.020 |
Why?
|
| Edema | 1 | 2011 | 147 | 0.020 |
Why?
|
| Consanguinity | 1 | 2010 | 120 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 103 | 0.020 |
Why?
|
| Aged | 1 | 2008 | 21448 | 0.020 |
Why?
|
| Mutation | 2 | 2016 | 6340 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2010 | 157 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2286 | 0.020 |
Why?
|
| Adult | 3 | 2015 | 31616 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 3794 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2016 | 1608 | 0.020 |
Why?
|
| Homozygote | 1 | 2010 | 561 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 982 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 1163 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1310 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 1118 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 1173 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 1351 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2011 | 709 | 0.020 |
Why?
|
| United States | 2 | 2013 | 11711 | 0.020 |
Why?
|
| Pedigree | 1 | 2010 | 1729 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 2784 | 0.010 |
Why?
|
| Base Sequence | 1 | 2010 | 3153 | 0.010 |
Why?
|
| Developmental Disabilities | 1 | 2010 | 739 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 965 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 3960 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 1849 | 0.010 |
Why?
|
| DNA | 1 | 2010 | 1675 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 4823 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 1307 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 1363 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2190 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 5435 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 4754 | 0.010 |
Why?
|
| Middle Aged | 2 | 2015 | 28912 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4574 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2007 | 13094 | 0.010 |
Why?
|